Tariffs will not only impact sponsors, but higher costs will ripple down the clinical trial supply chain in the US.

A pair of Chinese manufacturers whose active pharmaceutical ingredients (API) were previously shipped to the U.S. | The FDA ...

Deborah McElhone, Head of Sustainability (Pharma) from CPI, argues that process intensification is a game changer for the ...

That’s the conclusion of hiring managers at four of the state’s leading life sciences companies who spoke at a recent career ...

“Companies are realizing that investing stateside can provide more control and resilience to the drug supply chain,” says Dymowski. She cites political tensions, import and export disruptions, and ...

Continuous manufacturing (CM) has become a contentious topic in the modern pharmaceutical lexicon, driven by divergent ...

Adragos Pharma, a global pharmaceutical contract development and manufacturing organization (CDMO) headquartered in Munich, ...

Faced with the encroaching threats of patent expirations and generics, biopharma companies in 2024 invested 33% more in licensing deals, on average, than in 2023 with an eye toward enriching their ...

The collaboration aims to enhance muscle-fiber growth, elongation and fusion into mature muscle tissue, while also boosting ...

In this webinar, Wayne Woodard, Chief Executive Officer of Argonaut Manufacturing Services, and Katie Edgar, Chief Business Officer of KBI Biopharma discuss the challenges unique to organizations ...